Pharmaceutical Investing PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
Pharmaceutical Investing PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
